Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

28.56 +1.16 (+4.23%)

Streaming Delayed Price Updated: 3:55 PM EST, Feb 6, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,093,533
Open	27.50
Bid (Size)	28.50 (700)
Ask (Size)	28.56 (900)
Prev. Close	27.40
Today's Range	26.66 - 28.70
52wk Range	27.23 - 75.29
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference

February 04, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

After a 60% Slide, One Fund Cuts Exposure to This Healthcare Tech Stock by $12.5 Million ↗

February 01, 2026

This healthcare technology firm develops robotic surgical systems for minimally invasive urology procedures targeting BPH treatment.

Via The Motley Fool

Performance

YTD	-7.2%	-7.2%
1 Month	-17.7%	-17.7%
3 Month	-8.8%	-8.8%
6 Month	-27.9%	-27.9%
1 Year	-61.3%	-61.3%

More News

PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City

January 26, 2026

From PROCEPT BioRobotics

Via GlobeNewswire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Where PROCEPT BioRobotics Stands With Analysts ↗

April 25, 2025

Via Benzinga

3 Underrated Robotics Stocks Poised for Huge Gains ↗

December 15, 2025

Via MarketBeat

PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025

November 20, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance

November 04, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

2 Robotics Stocks Riding the Sensor and Medical Boom ↗

October 29, 2025

Via The Motley Fool

Is Procept BioRobotics Stock a Buy After Investment Company Chicago Capital Scoops Up Nearly 1 Million Shares? ↗

October 24, 2025

Via The Motley Fool

Beyond The Numbers: 4 Analysts Discuss PROCEPT BioRobotics Stock ↗

October 15, 2025

Via Benzinga

PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025

October 15, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts ↗

September 02, 2025

Via Benzinga

Procept (PRCT) Q2 Revenue Jumps 48% ↗

August 06, 2025

Via The Motley Fool

PROCEPT BioRobotics (PRCT) Earnings Transcript ↗

August 06, 2025

Via The Motley Fool

PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline ↗

August 06, 2025

Via Chartmill

PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

August 06, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

Uncovering Potential: PROCEPT BioRobotics's Earnings Preview ↗

August 05, 2025

Via Benzinga

PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO

July 24, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy

July 23, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025

July 21, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

July 14, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June

April 29, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops

April 24, 2025

From PROCEPT BioRobotics

Via GlobeNewswire

Frequently Asked Questions

Is PROCEPT BioRobotics Corporation - Common Stock publicly traded?

Yes, PROCEPT BioRobotics Corporation - Common Stock is publicly traded.

What exchange does PROCEPT BioRobotics Corporation - Common Stock trade on?

PROCEPT BioRobotics Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for PROCEPT BioRobotics Corporation - Common Stock?

The ticker symbol for PROCEPT BioRobotics Corporation - Common Stock is PRCT on the Nasdaq Stock Market

What is the current price of PROCEPT BioRobotics Corporation - Common Stock?

The current price of PROCEPT BioRobotics Corporation - Common Stock is 28.56

When was PROCEPT BioRobotics Corporation - Common Stock last traded?

The last trade of PROCEPT BioRobotics Corporation - Common Stock was at 02/06/26 03:55 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.